Ranbaxy Q3 Net Loss Widens to Rs 1,029.72 Crore

Published: 28th January 2015 03:42 PM  |   Last Updated: 28th January 2015 03:42 PM   |  A+A-


NEW DELHI: Drug major Ranbaxy Laboratories today reported a consolidated net loss of Rs 1,029.72 crore for the third quarter ended December 31, 2014-15.

The company had posted a net loss of Rs 158.94 crore during the October-December period of previous fiscal.

Net sales of the company declined to Rs 2,587.59 crore, as compared to Rs 2,858.96 crore during the same period of 2013-14, Ranbaxy Laboratories said in a statement.

Ranbaxy shares were trading at Rs 686.60 apiece, down 2.87 per cent, on the BSE.

Stay up to date on all the latest Business news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp